ArticleHuman vaccines & immunotherapeutics2018

Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform.

Lisa D MacDonald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.